Related Experiment Videos
A thoracic benign mesenchymoma in association with hemihypertrophy
American Journal of Clinical Pathology
|December 1, 1981
Summary
A large benign mesenchymoma was surgically removed from a patient with hemihypertrophy. Long-term monitoring is recommended for patients with hemihypertrophy due to their increased risk of developing neoplasms.
Area of Science:
- Thoracic oncology
- Surgical pathology
- Genetics and rare diseases
Background:
- Benign mesenchymomas are rare tumors.
- Hemihypertrophy is a congenital condition characterized by asymmetric overgrowth of body parts.
- Patients with hemihypertrophy have an increased risk of developing various neoplasms.
Observation:
- An 18-year-old male with hemihypertrophy presented with a large thoracic benign mesenchymoma.
- The tumor was composed of mature vascular spaces, adipose tissue, and smooth muscle.
- Surgical excision of the tumor was performed.
Findings:
- The patient experienced no recurrence of the benign mesenchymoma one year post-surgery.
- Histopathological analysis confirmed the benign nature and mixed cellular composition of the tumor.
- No complications were reported following the surgical removal.
Implications:
- This case highlights a rare presentation of benign mesenchymoma in a patient with hemihypertrophy.
- It underscores the importance of lifelong surveillance for individuals with hemihypertrophy due to their predisposition to neoplasms.
- Early detection and management of tumors in this population are crucial for favorable outcomes.